| 06/08/2026 3:32 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2026 1:52 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/02/2026 5:38 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 11:26 AM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/21/2026 3:48 PM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/21/2026 3:52 PM | PFEIFFER GARY M (1127304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/08/2026 3:15 PM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/01/2026 3:15 PM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/30/2026 12:08 PM | Quest Diagnostics (1022079) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 04/29/2026 1:39 PM | Quest Diagnostics (1022079) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G | |
| 04/28/2026 4:22 PM | Quest Diagnostics (1022079) Filer | Form 424B2 Transaction specifc information for a delayed shelf offering | |
Get the Latest News and Ratings for DGX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Quest Diagnostics and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/27/2026 3:17 PM | Quest Diagnostics (1022079) Subject | Form FWP | |
| 04/27/2026 7:47 AM | Quest Diagnostics (1022079) Filer | Form 424B2 Transaction specifc information for a delayed shelf offering | |
| 04/24/2026 5:23 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:23 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:23 PM | Lassiter Wright III (1805909) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:23 PM | CARTER ROBERT B (1197607) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:24 PM | Gregg Vicky B (1510304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:24 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:24 PM | Quest Diagnostics (1022079) Issuer SAMAD SAM (1694295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:12 PM | Quest Diagnostics (1022079) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/21/2026 5:48 AM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/06/2026 3:32 PM | Quest Diagnostics (1022079) Filer | Form DEF 14A | |
| 04/06/2026 3:33 PM | Quest Diagnostics (1022079) Filer | Form DEFA14A | |
| 04/02/2026 4:16 PM | Quest Diagnostics (1022079) Issuer WENTWORTH TIMOTHY C (1252016) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 10:36 AM | Quest Diagnostics (1022079) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/11/2026 5:03 PM | Quest Diagnostics (1022079) Issuer WENTWORTH TIMOTHY C (1252016) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/11/2026 5:05 PM | Quest Diagnostics (1022079) Issuer WENTWORTH TIMOTHY C (1252016) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:44 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:44 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:44 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:44 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:45 PM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:45 PM | Quest Diagnostics (1022079) Issuer SAMAD SAM (1694295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:43 PM | Deppe Michael J (1771759) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:43 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 10:53 AM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/05/2026 9:55 AM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/05/2026 9:43 AM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/04/2026 3:37 PM | Deppe Michael J (1771759) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:37 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
SpaceX IPO hides a much bigger story (Ad) The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself.
Elon believes what Michael Robinson calls 'Project Unlimited' could unlock $100 trillion in potential growth. One little-known company sits at the center of it all, and most investors have no idea it exists.
Position yourself before this company potentially hits the front page. Click here to see the details before the crowd catches on |
| 03/04/2026 3:37 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:38 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:38 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:38 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:39 PM | Quest Diagnostics (1022079) Issuer SAMAD SAM (1694295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:39 PM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 11:53 AM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/03/2026 11:12 AM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/03/2026 10:52 AM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/02/2026 1:21 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/20/2026 4:06 PM | Gregg Vicky B (1510304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:07 PM | CARTER ROBERT B (1197607) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:08 PM | Lassiter Wright III (1805909) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:09 PM | Deppe Michael J (1771759) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:10 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:10 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:11 PM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:11 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:12 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:12 PM | Quest Diagnostics (1022079) Issuer SAMAD SAM (1694295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:13 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/19/2026 9:34 AM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/19/2026 9:19 AM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/19/2026 9:23 AM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/10/2026 11:46 AM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/10/2026 5:53 AM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/12/2026 3:37 PM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/28/2025 3:30 PM | Gregg Vicky B (1510304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/28/2025 3:30 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 3:24 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/25/2025 8:42 AM | Gregg Vicky B (1510304) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/18/2025 10:02 AM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/07/2025 3:29 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:11 PM | Quest Diagnostics (1022079) Issuer SAMAD SAM (1694295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:09 PM | CARTER ROBERT B (1197607) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:09 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:10 PM | Gregg Vicky B (1510304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:10 PM | PFEIFFER GARY M (1127304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:11 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:11 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2025 1:10 PM | PFEIFFER GARY M (1127304) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/21/2025 5:50 AM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/21/2025 5:31 AM | Quest Diagnostics (1022079) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 09/30/2025 3:36 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/26/2025 3:12 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/25/2025 3:39 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/24/2025 3:10 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/23/2025 3:14 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/25/2025 3:27 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2025 3:34 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Why this tiny stock may move before the SpaceX IPO drops (Ad) The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillion in stored capital will be looking for a home when it does.
But the real opportunity isn't the IPO itself. Jovine has identified a small-cap supplier trading near $4 that sits directly in the path of xAI's Colossus infrastructure buildout - and a specific trigger in the S-1 could reprice it overnight. Get the ticker and full briefing before the June roadshow begins |
| 08/21/2025 11:10 AM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/15/2025 4:22 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/15/2025 4:25 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/15/2025 4:29 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/08/2025 3:40 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/06/2025 12:54 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/31/2025 1:27 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/25/2025 3:25 PM | CARTER ROBERT B (1197607) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/25/2025 3:26 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |